Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.23.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
REVENUES $ 1,848 $ 1,868
COST OF REVENUES 1,160 1,286
GROSS PROFIT 688 582
OPERATING EXPENSES:    
Research and development expenses, net 757 650
Sales and marketing expenses, net 929 730
General and administrative expenses, net 865 635
TOTAL OPERATING EXPENSES 2,551 2,015
OPERATING LOSS (1,863) (1,433)
Interest expenses (180) (220)
Other Financial income (expenses), net 148 (2,986)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,895) $ (4,639)
Net loss per share attributable to common shareholders – basic (in Dollars per share) [1] $ (1.09) $ (22.6)
Weighted average number of shares of common stock used in computing net loss per share – basic (in Shares) 1,734,160 205,213
[1] Adjusted to reflect reverse stock split, see note 3(j).